These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7207081)

  • 21. Multiple drug therapy--is there a standard of care?
    Goldstein EM
    J Leg Med (N Y); 1977 Sep; 5(9):41-5. PubMed ID: 302849
    [No Abstract]   [Full Text] [Related]  

  • 22. Costs drive acceptance of transgenic bioassays.
    Swan N
    Nat Biotechnol; 1998 Oct; 16(10):902-3. PubMed ID: 9788336
    [No Abstract]   [Full Text] [Related]  

  • 23. A prescription for cutting health care costs.
    Caring; 1992 Nov; 11(11):10-4. PubMed ID: 10121247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diethylstilbestrol-medicolegal chronology.
    Weitzner K; Candidate JD; Hirsh HL
    Med Trial Tech Q; 1981; 28(2):145-70. PubMed ID: 7334927
    [No Abstract]   [Full Text] [Related]  

  • 25. Medication managers cut drug costs.
    Scott L
    Mod Healthc; 1996 Nov; 26(46):86. PubMed ID: 10163081
    [No Abstract]   [Full Text] [Related]  

  • 26. Relative efficacy.
    Stetler CJ
    J Med Assoc Ga; 1972 Sep; 61(9):312-5. PubMed ID: 5080001
    [No Abstract]   [Full Text] [Related]  

  • 27. [Quo vadis medicina? 15. Drug trials in the United States today].
    Müller-Ehrenberg KH
    Hippokrates; 1968 Feb; 39(3):105-7. PubMed ID: 5721794
    [No Abstract]   [Full Text] [Related]  

  • 28. Market watch : Pharma industry strategic performance: 2007-2012E.
    Goodman M
    Nat Rev Drug Discov; 2008 Dec; 7(12):967. PubMed ID: 19043444
    [No Abstract]   [Full Text] [Related]  

  • 29. Lilly, DES and the law.
    Am Fam Physician; 1981 Jul; 24(1):89-90. PubMed ID: 7258071
    [No Abstract]   [Full Text] [Related]  

  • 30. Dismissing the evidence: the medical response to women with silicone implant-related disorders.
    Dumble LJ
    Health Care Women Int; 1996; 17(6):515-25. PubMed ID: 9119771
    [No Abstract]   [Full Text] [Related]  

  • 31. Herbal Rx: the promises and pitfalls.
    Consum Rep; 1999 Mar; 64(3):44-8. PubMed ID: 10557627
    [No Abstract]   [Full Text] [Related]  

  • 32. "Disinformation" from pharmaceutical company representatives.
    Gordon M
    CMAJ; 1990 Jun; 142(11):1177-8. PubMed ID: 2344567
    [No Abstract]   [Full Text] [Related]  

  • 33. The older adult and drug therapy: Part two. Thirteen drugs and what they cost.
    Geriatr Nurs; 1982; 3(1):48-9. PubMed ID: 6916681
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: The pharmacist and drug product selection.
    Tice LF
    Am J Pharm Sci Support Public Health; 1974; 146(3):67-9. PubMed ID: 4851580
    [No Abstract]   [Full Text] [Related]  

  • 35. Urgent--drug recall. How well does the system work?
    Small WE
    Am Pharm; 1980 Aug; NS20(8):17-9. PubMed ID: 7424773
    [No Abstract]   [Full Text] [Related]  

  • 36. Science, drugs, and the Food and Drug Administration.
    De Haen P
    N Y State J Med; 1971 Jul; 71(13):1644-50. PubMed ID: 5284708
    [No Abstract]   [Full Text] [Related]  

  • 37. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness data on biologics needed.
    Sheridan C; Katsnelson A
    Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069
    [No Abstract]   [Full Text] [Related]  

  • 39. Can "phase IV" trials work for you?
    Borfitz D
    Med Econ; 2003 Jun; 80(11):58, 64, 67. PubMed ID: 12828120
    [No Abstract]   [Full Text] [Related]  

  • 40. Validation--how much can the world afford? Are we getting value for money?
    Anisfeld MH
    J Pharm Sci Technol; 1994; 48(1):45-8. PubMed ID: 8004419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.